Q3 2023 Holdings
Filed 2023-11-14 | 87 holdings | $1.9B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Royalty Pharma PLC(RPRX) | SHS CLASS A | G7709Q104 | $111.2M | 4,095,745 | 6.0% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $104.2M | 4,005,600 | 5.6% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $103.0M | 2,869,967 | 5.6% |
| Horizon Therapeutics PUB L | SHS | G46188101 | $91.0M | 786,313 | 4.9% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $87.0M | 3,446,334 | 4.7% |
| Meta Platforms Inc(META) | CL A | 30303M102 | $84.3M | 280,645 | 4.6% |
| Amazon COM Inc(AMZN) | COM | 023135106 | $78.7M | 619,469 | 4.3% |
| Advanced Micro Devices Inc(AMD) | COM | 007903107 | $71.6M | 696,510 | 3.9% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $71.4M | 1,369,849 | 3.9% |
| Microsoft Corp(MSFT) | COM | 594918104 | $68.9M | 218,170 | 3.7% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $66.9M | 7,335,845 | 3.6% |
| Wynn Resorts LTD(WYNN) | COM | 983134107 | $42.5M | 460,048 | 2.3% |
| Marinus Pharmaceuticals Inc(MRNS*) | COM NEW | 56854Q200 | $41.9M | 5,204,942 | 2.3% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $41.6M | 2,694,404 | 2.2% |
| General Electric Co(GE) | COM NEW | 369604301 | $38.8M | 350,969 | 2.1% |
| Nvidia Corporation(NVDA) | COM | 67066G104 | $38.5M | 88,548 | 2.1% |
| Chipotle Mexican Grill Inc(CMG) | COM | 169656105 | $37.4M | 20,400 | 2.0% |
| Global Pmts Inc(GPN) | COM | 37940X102 | $32.8M | 284,488 | 1.8% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $30.4M | 6,041,910 | 1.6% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $29.8M | 3,053,300 | 1.6% |
| LAS Vegas Sands Corp(LVS) | COM | 517834107 | $29.5M | 642,833 | 1.6% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $27.9M | 3,492,147 | 1.5% |
| Oracle Corp(ORCL) | COM | 68389X105 | $27.0M | 255,311 | 1.5% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $25.4M | 5,718,881 | 1.4% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $24.2M | 679,459 | 1.3% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $23.3M | 2,420,851 | 1.3% |
| RH(RH) | COM | 74967X103 | $21.4M | 80,989 | 1.2% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $21.0M | 39,100 | 1.1% |
| Sutro Biopharma Inc | COM | 869367102 | $20.4M | 5,883,693 | 1.1% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $20.3M | 1,010,976 | 1.1% |
| Zura BIO LTD(ZURA) | CLASS A ORD SHS | G9TY5A101 | $18.8M | 2,850,000 | 1.0% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $18.7M | 353,741 | 1.0% |
| Prokidney Corp(PROK) | CLASS A ORD SHS | G7S53R104 | $17.7M | 3,867,843 | 1.0% |
| Capital One Finl Corp(COF) | COM | 14040H105 | $17.6M | 181,660 | 1.0% |
| Wells Fargo Co New(WFC) | COM | 949746101 | $17.5M | 428,506 | 0.9% |
| Apollo Global Mgmt Inc(APO) | COM | 03769M106 | $17.2M | 191,900 | 0.9% |
| Hilton Worldwide Hldgs Inc(HLT) | COM | 43300A203 | $17.1M | 113,962 | 0.9% |
| Inflarx NV(IFRX) | COM | N44821101 | $17.1M | 5,733,910 | 0.9% |
| Mckesson Corp(MCK) | COM | 58155Q103 | $16.3M | 37,540 | 0.9% |
| Johnson & Johnson(JNJ) | COM | 478160104 | $14.0M | 90,097 | 0.8% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $13.7M | 27,223 | 0.7% |
| Sana Biotechnology Inc(SANA) | COM | 799566104 | $11.5M | 2,963,704 | 0.6% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $11.2M | 454,000 | 0.6% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $10.7M | 597,099 | 0.6% |
| Mereo Biopharma Group PLC(MREO) | SPON ADS | 589492107 | $9.5M | 7,364,438 | 0.5% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $8.6M | 479,445 | 0.5% |
| Kezar Life Sciences Inc | COM | 49372L100 | $8.5M | 7,167,591 | 0.5% |
| Alvotech(ALVO) | ORDINARY SHARES | L01800108 | $8.5M | 928,402 | 0.5% |
| Sanofi(SNY) | SPONSORED ADR | 80105N105 | $6.2M | 116,041 | 0.3% |
| Elanco Animal Health Inc(ELAN) | COM | 28414H103 | $6.0M | 536,500 | 0.3% |